yttrium radioisotopes has been researched along with Lung Neoplasms in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (11.90) | 18.7374 |
1990's | 5 (11.90) | 18.2507 |
2000's | 15 (35.71) | 29.6817 |
2010's | 15 (35.71) | 24.3611 |
2020's | 2 (4.76) | 2.80 |
Authors | Studies |
---|---|
Barron, B; Bercu, Z; Brandon, D; Cheng, B; Elsayed, M; Galt, J; Kokabi, N; Schuster, DM; Sethi, I; Xing, M | 1 |
Apostolopoulos, D; Hazle, JD; Kagadis, GC; Katsanos, K; Mountris, KA; Papadimitroulas, P; Papathanasiou, N; Plachouris, D; Spyridonidis, T; Visvikis, D | 1 |
Higashi, T; Kaneko, MK; Kato, Y; Saga, T; Sudo, H; Sugyo, A; Tsuji, AB | 1 |
Abdullah, BJJ; Guatelli, S; Hashikin, NAA; Malaroda, A; Ng, KH; Perkins, AC; Rosenfeld, A; Yeong, CH | 1 |
Banks, M; Cuthbertson, DJ; Gilbert, TM; Maltby, P; McKane, G; Palmer, DH; Poston, G; Pritchard, DM; Vinjamuri, S; Vora, J; Weissman, H | 1 |
Amthauer, H; Großer, O; Ricke, J | 1 |
Kao, YH | 1 |
Amthauer, H; Grosser, OS; Ricke, J | 1 |
Baete, K; Bogaerts, K; Clement, PM; Deroose, CM; Haustermans, K; Koole, M; Mortelmans, L; Mottaghy, FM; Terwinghe, C; Van Binnebeek, S; Van Cutsem, E; Vanbilloen, B; Verbruggen, A; Verslype, C | 1 |
Fujiwara, K; Fukayama, M; Hamakubo, T; Hino, A; Ikemura, M; Iwanari, H; Kasahara, H; Kodama, T; Koyama, K; Kusano-Arai, O; Mitsui, K; Momose, T; Saito, Y; Suga, K | 1 |
Feron, O; Gallez, B; Lucas, S; Masereel, B; Michiels, C; Vander Borght, T | 1 |
Camacho, JC; Kim, HS; Kokabi, N; Lahti, S; Schuster, DM; Xing, M | 1 |
Bhatt, S; Camacho, JC; Ghodadra, A; Kim, HS | 1 |
Geramifar, P; Kamali Asl, A; Khazaee Moghadam, M; Zaidi, H | 1 |
Ellis, S; Hahl, M; Martin, RC; McMasters, K; Scoggins, CR; Tatum, C; Whitney, R | 1 |
Apostolidis, C; Esaias, C; Hobbs, RF; Huso, DL; Morgenstern, A; Sgouros, G; Song, H; Vajravelu, R | 1 |
Agazzi, A; Aricò, D; Bodei, L; De Cicco, C; De Simone, M; Pacifici, M; Paganelli, G; Quarna, J; Sansovini, M; Sierra, ML | 1 |
Coldwell, D; Kennedy, A; Salem, R; Sangro, B; Wasan, H | 1 |
Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Katagiri, T; Nakagawa, H; Nakamura, Y; Oriuchi, N; Osawa, R; Paudyal, P; Shiba, Y; Tominaga, H; Tsunoda, T; Yamamoto, S; Yoshida, K; Yoshioka, H | 1 |
Duan, J; Khazaeli, MB; LoBuglio, AF; Macey, DJ; Meredith, RF; Robert, F; Shen, S | 1 |
Busby, EM; LoBuglio, AF; Robert, F | 1 |
DUDLEY, HC; GREENBERG, J | 1 |
Bouterfa, H; Bushnell, D; Carlisle, T; Connolly, M; Kahn, D; Karwal, M; Madsen, M; Menda, Y; Miller, S; O'Dorisio, S; O'Dorisio, T; Ponto, J; Squires, S; Walkner, W | 1 |
Buitrago, C; Herrmann, R; Maecke, H; Mueller-Brand, J; Pless, M; Waldherr, C | 1 |
Busby, E; Carey, D; Forero, A; Grizzle, WE; Khazaeli, MB; LoBuglio, AF; Meredith, RF; Robert, F; Shen, S | 1 |
Bockisch, A; Broelsch, CE; Frilling, A; Hofmann, M; Mueller-Brand, J; Saner, F; Weber, F | 1 |
Du, Y; Frey, E; Prideaux, A; Sgouros, G; Song, H; Wahl, RL | 1 |
DeMonaco, NA; Jacobs, SA; Joyce, J; McCarty, KS | 1 |
Becker, M; Brod, KH; Dähnert, W; Grimm, W; Kutzner, J; Schreyer, T | 1 |
Boecker, BB; Cuddihy, RG; Hahn, FF; Hobbs, CH; McClellan, RO; Snipes, MB | 1 |
Hahn, FF; Lundgren, DL; McClellan, RO | 1 |
Blumenthal, R; Goldenberg, DM; Sharkey, RM; Stein, R | 1 |
Chen, S; Goldenberg, DM; Haim, S; Stein, R | 1 |
Boecker, BB; Diel, JH; Griffith, WC; Hahn, FF; Hubbs, AF; Muggenburg, BA; Newton, GJ; Snipes, MB | 1 |
Brechbiel, M; Kennel, SJ; Mirzadeh, S; Stabin, M; Yoriyaz, H | 1 |
Crazzolara, A; Haldemann, A; Maecke, HR; Mueller-Brand, J; Waldherr, C | 1 |
Bakker, W; Chen, T; Jamar, F; Krenning, E; Kvols, L; Liu, J; Pauwels, S; Schran, H; Smith, MC; Valkema, R; Yeh, CM | 1 |
Chu, DZ; Doroshow, JH; Liu, A; Raubitschek, AA; Shively, JE; Wilczynski, S; Williams, LE; Wu, AM; Yamauchi, DM | 1 |
Chen, S; Goldenberg, DM; Govindan, SV; Griffiths, GL; Hansen, HJ; Reed, L; Richel, H; Stein, R | 1 |
Dworkin, HJ; Gates, VL; Raman, S; Salem, R; Wong, CY | 1 |
Benjamin, SA; Boecker, BB; Hahn, FF; Hobbs, CH; Jones, RK; McClellan, RO; Snipes, MB | 1 |
Beyer, GJ; Bockisch, A; Grimm, W; Hahn, K; Kutzner, J; Rösler, HP | 1 |
2 review(s) available for yttrium radioisotopes and Lung Neoplasms
Article | Year |
---|---|
Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Glass; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Microspheres; Resins, Synthetic; Treatment Outcome; Uveal Neoplasms; Yttrium Radioisotopes | 2012 |
OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy.
Topics: Animals; Breast Neoplasms; Carcinoma, Small Cell; Dose-Response Relationship, Radiation; Female; Humans; Indium Radioisotopes; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasms; Neuroendocrine Tumors; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Yttrium Radioisotopes | 2000 |
9 trial(s) available for yttrium radioisotopes and Lung Neoplasms
Article | Year |
---|---|
Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy.
Topics: Adult; Aged; Digestive System Neoplasms; Female; Humans; Kidney; Kidney Function Tests; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Precision Medicine; Radiation Dosage; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Yttrium Radioisotopes | 2014 |
Improved prediction of myelotoxicity using a patient-specific imaging dose estimate for non-marrow-targeting (90)Y-antibody therapy.
Topics: Adult; Aged; Animals; Antigens, Neoplasm; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Glycoproteins; Humans; Indium Radioisotopes; Lumbar Vertebrae; Lung Neoplasms; Mice; Middle Aged; Radiation Dosage; Radioimmunotherapy; Radiometry; Thrombocytopenia; Yttrium Radioisotopes | 2002 |
Chemotherapy tolerance after radioimmunotherapy with 90Y-CC49 monoclonal antibody in patients with advanced non-small cell lung cancer: clinical effects and hematologic toxicity.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Tolerance; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Radioimmunotherapy; Retrospective Studies; Salvage Therapy; Treatment Outcome; Yttrium Radioisotopes | 2003 |
Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment.
Topics: Adult; Aged; Amino Acids; Arginine; Carcinoid Tumor; Female; Humans; Infusions, Intravenous; Kidney; Lung Neoplasms; Lysine; Male; Meningioma; Middle Aged; Octreotide; Pancreatic Neoplasms; Radiopharmaceuticals; Yttrium Radioisotopes | 2004 |
Targeted radiotherapy for small cell lung cancer using 90Yttrium-DOTATOC, an Yttrium-labelled somatostatin analogue: a pilot trial.
Topics: Aged; Carcinoma, Small Cell; Disease Progression; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Yttrium Radioisotopes | 2004 |
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chelating Agents; Clinical Trials as Topic; Disease Progression; Edetic Acid; Female; Glycoproteins; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Pentetic Acid; Radioimmunotherapy; Radiometry; Thrombocytopenia; Treatment Outcome; Up-Regulation; Yttrium Radioisotopes | 2005 |
Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumors.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Lutetium; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Treatment Outcome; Yttrium Radioisotopes | 2006 |
A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow; Carcinoembryonic Antigen; Colorectal Neoplasms; Humans; Immunoglobulin G; Liver; Lung Neoplasms; Mice; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Recombinant Fusion Proteins; Thyroid Neoplasms; Time Factors; Yttrium Radioisotopes | 2000 |
Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2002 |
31 other study(ies) available for yttrium radioisotopes and Lung Neoplasms
Article | Year |
---|---|
Comparison of Tc-99m MAA Planar Versus SPECT/CT Imaging for Lung Shunt Fraction Evaluation Prior to Y-90 Radioembolization: Are We Overestimating Lung Shunt Fraction?
Topics: Brachytherapy; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Lung; Lung Neoplasms; Male; Middle Aged; Organs at Risk; Radionuclide Imaging; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2021 |
Clinical Evaluation of a Three-Dimensional Internal Dosimetry Technique for Liver Radioembolization with
Topics: Algorithms; Dimensional Measurement Accuracy; Dose-Response Relationship, Radiation; Embolization, Therapeutic; Humans; Imaging, Three-Dimensional; Liver Neoplasms; Lung Neoplasms; Microspheres; Monte Carlo Method; Positron Emission Tomography Computed Tomography; Radiometric Dating; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Single Photon Emission Computed Tomography Computed Tomography; Yttrium Radioisotopes | 2021 |
Therapeutic efficacy evaluation of radioimmunotherapy with
Topics: Animals; Antibodies, Monoclonal; Antibody-Dependent Cell Cytotoxicity; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Indium Radioisotopes; Lung Neoplasms; Male; Membrane Glycoproteins; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, Nude; Radioimmunotherapy; Rats; Treatment Outcome; Up-Regulation; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2019 |
Systematic investigation on the validity of partition model dosimetry for
Topics: Adult; Brachytherapy; Humans; Liver Neoplasms; Lung Neoplasms; Monte Carlo Method; Phantoms, Imaging; Radiometry; Radiotherapy Planning, Computer-Assisted; Yttrium Radioisotopes | 2017 |
Peptide receptor radionuclide therapy with (90)Y-DOTATATE/(90)Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity.
Topics: Female; Humans; Intestinal Neoplasms; Intestine, Small; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Radiopharmaceuticals; Receptors, Peptide; Retrospective Studies; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Y90-radioembolization of lung metastases via the bronchial artery: a report of 2 cases.
Topics: Aged; Bronchial Arteries; Colorectal Neoplasms; Embolization, Therapeutic; Feasibility Studies; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Microspheres; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2013 |
General theory of predictive dosimetry for yttrium-90 radioembolization to sites other than the liver.
Topics: Bronchial Arteries; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Multimodal Imaging; Splenomegaly; Yttrium Radioisotopes | 2014 |
General theory of predictive dosimetry for yttrium-90 radioembolization to sites other than the liver: reply.
Topics: Bronchial Arteries; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Yttrium Radioisotopes | 2014 |
90Y-Labeled Anti-ROBO1 Monoclonal Antibody Exhibits Antitumor Activity against Small Cell Lung Cancer Xenografts.
Topics: Animals; Antibodies, Monoclonal; Humans; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Nerve Tissue Proteins; Radioimmunotherapy; Receptors, Immunologic; Roundabout Proteins; Small Cell Lung Carcinoma; Tissue Distribution; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2015 |
Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts.
Topics: Algorithms; Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Computer Simulation; Humans; Iodine Radioisotopes; Lung; Lung Neoplasms; Lutetium; Models, Statistical; Monte Carlo Method; Nanomedicine; Neoplasms; Radiation Pneumonitis; Radioimmunotherapy; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Rhenium; Yttrium Radioisotopes | 2015 |
90Y Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pulmonary Ventilation; Radionuclide Imaging; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tumor Burden; Yttrium Radioisotopes | 2016 |
Abscopal Effects and Yttrium-90 Radioembolization.
Topics: Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Embolization, Therapeutic; Humans; Liver Neoplasms; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Regression, Spontaneous; Neoplasms, Multiple Primary; Palliative Care; Tumor Burden; Yttrium Radioisotopes | 2016 |
Evaluating the Application of Tissue-Specific Dose Kernels Instead of Water Dose Kernels in Internal Dosimetry: A Monte Carlo Study.
Topics: Algorithms; Bone Neoplasms; Computer Simulation; Humans; Liver Neoplasms; Lung Neoplasms; Lutetium; Monte Carlo Method; Organ Specificity; Phosphorus Radioisotopes; Radioisotopes; Radiometry; Radionuclide Imaging; Radiotherapy Planning, Computer-Assisted; Water; Yttrium Radioisotopes | 2016 |
Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy.
Topics: Adult; Carcinoma, Adenosquamous; Cholangiocarcinoma; Colorectal Neoplasms; Combined Modality Therapy; Female; Gastrinoma; Gastrointestinal Neoplasms; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Microspheres; Middle Aged; Radiotherapy; Registries; Sarcoma; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Female; Immunotoxins; Isotope Labeling; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Radioimmunotherapy; Radioisotopes; Rats; Receptor, ErbB-2; Tissue Distribution; Yttrium Radioisotopes | 2009 |
Lymphocytic toxicity in patients after peptide-receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOC.
Topics: Adult; Aged; B-Lymphocytes; Colonic Neoplasms; Duodenal Neoplasms; Female; Humans; Ileal Neoplasms; Lung Neoplasms; Lutetium; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Yttrium Radioisotopes | 2009 |
In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Blotting, Western; Cadherins; Cell Line, Tumor; Colorectal Neoplasms; Female; Flow Cytometry; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Radioimmunotherapy; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2012 |
Circumscribed neoplastic lesions; a new modality for therapy.
Topics: Animals; Brain Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasms, Experimental; Yttrium; Yttrium Radioisotopes | 1957 |
Therapeutic potential of 90Y- and 131I-labeled anti-CD20 monoclonal antibody in treating non-Hodgkin's lymphoma with pulmonary involvement: a Monte Carlo-based dosimetric analysis.
Topics: Adult; Antigens, CD20; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Monte Carlo Method; Neoplasm Metastasis; Phantoms, Imaging; Radioimmunotherapy; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Software; Yttrium Radioisotopes | 2007 |
Focal radiation fibrosis after radioimmunotherapy for follicular non-Hodgkin lymphoma.
Topics: Aged; Antibodies, Monoclonal; Diagnosis, Differential; Dose-Response Relationship, Radiation; Humans; Laryngeal Neoplasms; Lung Neoplasms; Lymphoma, Follicular; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Pneumonitis; Radioimmunotherapy; Recurrence; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
[Treatment of pains from bone metastases with 90Y (author's transl)].
Topics: Bone Neoplasms; Breast Neoplasms; Female; Half-Life; Humans; Lung Neoplasms; Male; Melanoma; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radiotherapy Dosage; Stomach Neoplasms; Yttrium Radioisotopes | 1981 |
Influence of radiation dose patterns on lung tumor incidence in dogs that inhaled beta emitters: a preliminary report.
Topics: Aerosols; Animals; Cerium Radioisotopes; Dogs; Dose-Response Relationship, Radiation; Electrons; Lung Neoplasms; Neoplasms, Radiation-Induced; Risk; Strontium Radioisotopes; Time Factors; Yttrium Radioisotopes | 1983 |
Toxicity of 90Y in relatively insoluble fused aluminosilicate particles when inhaled by mice.
Topics: Aerosols; Animals; Bentonite; Body Burden; Dogs; Half-Life; Lung; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Pneumonia; Radiation Dosage; Radiation Injuries, Experimental; Risk; Yttrium Radioisotopes | 1981 |
Comparative biodistribution and radioimmunotherapy of monoclonal antibody RS7 and its F(ab')2 in nude mice bearing human tumor xenografts.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Female; Humans; Immunoglobulin Fab Fragments; Immunotoxins; Indium Radioisotopes; Iodine Radioisotopes; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Radiation Dosage; Radioimmunotherapy; Tissue Distribution; Transplantation, Heterologous; Uterine Cervical Neoplasms; Yttrium Radioisotopes | 1994 |
Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft.
Topics: Animals; Antibodies, Monoclonal; Female; Humans; Iodine Radioisotopes; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Radioimmunotherapy; Transplantation, Heterologous; Yttrium Radioisotopes | 1997 |
Toxicity of inhaled 91YCl3 in dogs.
Topics: Administration, Inhalation; Animals; Blood Cells; Cause of Death; Dogs; Female; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Neoplasms, Radiation-Induced; Radiation Dosage; Tissue Distribution; Yttrium Radioisotopes | 1998 |
Treatment of lung tumor colonies with 90Y targeted to blood vessels: comparison with the alpha-particle emitter 213Bi.
Topics: Animals; Antibodies, Monoclonal; Bismuth; Dose-Response Relationship, Radiation; Female; Isothiocyanates; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, SCID; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Yttrium Radioisotopes | 1999 |
Exceptional results in neuroendocrine-metastases-caused paraplegia treated with [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC), a radiolabelled somatostatin analogue.
Topics: Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Paraplegia; Radiopharmaceuticals; Somatostatin; Spinal Cord Compression; Spinal Neoplasms; Thoracic Vertebrae; Yttrium Radioisotopes | 2000 |
Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I.
Topics: Animals; Antibodies, Monoclonal; Female; Glycoproteins; Heterocyclic Compounds, 1-Ring; Humans; Iodine Radioisotopes; Lung Neoplasms; Lutetium; Mice; Mice, Nude; Neoplasm Transplantation; Radioimmunotherapy; Radioisotopes; Tissue Distribution; Tumor Cells, Cultured; Yttrium Radioisotopes | 2001 |
Comparative pulmonary carcinogenicity of inhaled beta-emitting radionuclides in beagle dogs.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aerosols; Animals; Carcinoma, Squamous Cell; Cerium Radioisotopes; Dogs; Female; Fibrosarcoma; Hemangiosarcoma; Lung Neoplasms; Male; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Radiation Dosage; Strontium Radioisotopes; Time Factors; Yttrium Radioisotopes | 1975 |
[Scintigraphic use of 87Y during 90Y therapy of bone metastases].
Topics: Aged; Bone Neoplasms; Carcinoma, Bronchogenic; Humans; Lung Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Radionuclide Imaging; Stomach Neoplasms; Yttrium Radioisotopes | 1992 |